I support to some degree your theory.
I believe somewhere in the Elanco option is some form of confidentiality clause that limits self promoting or Elanco /Eli lilly are somehow accumulating shares and surpressing the share price espicially after the phase 2 dog trial or and are controlling the way the info is released.The real detail is in the dosier which we wont see till Elanco take up their option!
Just a theory
Regards
smartchemist
Ann: Preliminary Positive Results for the Treatment of SARS-CoV-2, page-276
Add NUZ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
0.010(5.26%) |
Mkt cap ! $98.34M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 20.5¢ | 19.5¢ | $86.20K | 429.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 67508 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 36444 | 3 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| NUZ (ASX) Chart |